Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 2
1981 1
1982 1
1983 3
1984 3
1985 2
1986 2
1987 5
1988 7
1989 3
1990 4
1991 7
1992 7
1993 9
1994 6
1995 11
1996 6
1997 5
1998 7
1999 2
2000 8
2001 6
2002 6
2003 4
2004 1
2005 6
2006 5
2007 4
2008 2
2009 2
2011 4
2012 4
2013 4
2014 6
2015 4
2016 2
2017 5
2018 2
2019 7
2020 6
2021 8
2022 6
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 12117873

186 results

Results by year

Filters applied: . Clear all
Page 1
Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial.
Gassull MA, Fernández-Bañares F, Cabré E, Papo M, Giaffer MH, Sánchez-Lombraña JL, Richart C, Malchow H, González-Huix F, Esteve M; Eurpoean Group on Enteral Nutrition in Crohn's Disease. Gassull MA, et al. Gut. 2002 Aug;51(2):164-8. doi: 10.1136/gut.51.2.164. Gut. 2002. PMID: 12117873 Free PMC article. Clinical Trial.
Enteral nutrition as primary therapy in Crohn's disease.
Fernández-Bañares F, Cabré E, González-Huix F, Gassull MA. Fernández-Bañares F, et al. Gut. 1994 Jan;35(1 Suppl):S55-9. doi: 10.1136/gut.35.1_suppl.s55. Gut. 1994. PMID: 8125393 Free PMC article. Review.
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial.
Yanai H, Levine A, Hirsch A, Boneh RS, Kopylov U, Eran HB, Cohen NA, Ron Y, Goren I, Leibovitzh H, Wardi J, Zittan E, Ziv-Baran T, Abramas L, Fliss-Isakov N, Raykhel B, Gik TP, Dotan I, Maharshak N. Yanai H, et al. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):49-59. doi: 10.1016/S2468-1253(21)00299-5. Epub 2021 Nov 2. Lancet Gastroenterol Hepatol. 2022. PMID: 34739863 Clinical Trial.
186 results